CymaBay Therapeutics, Inc.
(23257D103)
Fondsberichterstattung Bestände von CymaBay Therapeutics, Inc. gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Baker BROS Advisors LP | 5,707,411 | $40,865k | Jun 30, 2019 | Aug 14, 2019 | |
| Redmile Group LLC | 3,138,365 | $22,471k | Jun 30, 2019 | Aug 14, 2019 | |
| Venbio Select Advisor LLC | 2,700,000 | $19,332k | Jun 30, 2019 | Aug 14, 2019 | |
| VIVO Capital LLC | 2,154,934 | $15,429k | Jun 30, 2019 | Aug 13, 2019 | |
| Ghost Tree Capital LLC | 1,000,000 | $7,160k | Jun 30, 2019 | Aug 14, 2019 | |
| Rock Springs Capital Management LP | 900,000 | $6,444k | Jun 30, 2019 | Aug 14, 2019 | |
| Dafna Capital Management LLC | 349,996 | $2,506k | Jun 30, 2019 | Aug 14, 2019 | |
| Spark Investment Management LLC | 242,200 | $1,734k | Jun 30, 2019 | Aug 12, 2019 | |
| Point72 Asset Management LP | 200,000 | $1,432k | Call | Jun 30, 2019 | Aug 14, 2019 |
| Lombard Odier Asset Management USA Corp | 145,000 | $1,038k | Jun 30, 2019 | Aug 14, 2019 | |
| Tekla Capital Management LLC | 88,102 | $631k | Jun 30, 2019 | Aug 14, 2019 | |
| Cambridge Investment Research Advisors Inc | 11,200 | $80k | Jun 30, 2019 | Aug 15, 2019 | |
| Prelude Capital Management LLC | 767 | $5k | Jun 30, 2019 | Aug 14, 2019 |